tert-Butyl (S)-((2-phenyl-5-pivalamido-3-pivaloyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)methyl)carbamate, 98%, 50mg

1-Hydroxy-2,2,6,6-tetramethylpiperidin-4-yl 3,3-bis((3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)butanoate (free radical), 97%, 250mg

(R)-2-Amino-3-chloropropanoic acid hydrochloride, 95.0%, 50g

L-Cystine, 100 g

3-(DIFLUOROMETHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE, 95.0%, 100mg

2-chloro-1-[1-(3,5-dichlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]ethanone, 250mg

5-(4-Chlorophenyl)thiazol-2-amine, 95.0%, 250mg

3,3-Diphenylpropyl Bromide>98.0%(GC)(T)25g

Methyl 2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)acetate, 95.0%, 250mg

1-(Tert-butyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

Petri dishes with aeration lugs, 90 x 16 mm, Non-sterile 480 pcs

N-2-Butyl-N'-isopropyl ethylenediamine, 1g

5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 95.0%, 1g